News
19h
Sarepta Therapeutics, Inc. ( NASDAQ: SRPT) Strategic Restructure and ELEVIDYS Label Update Conference Call July 16, 2025 4:30 PM ET Douglas S. Ingram - President, CEO & Director Ian Estepan - ...
ALK ( ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EUR neffy® 2 mg in the United Kingdom (UK) for anaphylaxis treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback